insights_auto
Why is ARGX down 4,09%?
Dive Deeperchevron_right
ARGX:EBR
argenx SE
€727,60
arrow_downward
-4,09%(-31,00) 1D
16 ຕ.ລ., 17 ໂມງ 39 ນາທີ 35 ວິນາທີ GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
€759,20
High
€761,80
Low
€727,60
Mkt. cap
48,36 ຕື້
Avg. vol.
86,90 ພັນ
Volume
96,25 ພັນ
P/E ratio
30,95
52-wk high
€925,00
52-wk low
€568,40
EPS
€23,51
Shares outstanding
35,93 ລ້ານ
No. of employees
2 ພັນ
Open
€759,20
High
€761,80
Low
€727,60
Mkt. cap
48,36 ຕື້
Avg. vol.
86,90 ພັນ
Volume
96,25 ພັນ
P/E ratio
30,95
52-wk high
€925,00
52-wk low
€568,40
EPS
€23,51
Shares outstanding
35,93 ລ້ານ
No. of employees
2 ພັນ
News stories
From web sources and news partners
ad-hoc-news.de
·
23 ຊົ່ວໂມງກ່ອນ
argenx reports trial results: what it means for argenx stock
TipRanks
·
1 ມື້ກ່ອນ
Argenx Stock Stumbles As Trial Failure Haunts Rally
ad-hoc-news.de
·
1 ມື້ກ່ອນ
Goldman lifts target for Argenx stock to EUR 959.00
Yahoo Finance
·
1 ມື້ກ່ອນ
Zacks Investment Ideas feature highlights: Cummins, Argenx and PACCAR
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE